Abstract
An efficient tandem and domino protocol for the synthesis of chromeno-, pyrano-, and quinolino- fused spiro[pyrazolo[3,4- b]pyridine-indolines] has been developed. The present method involves one-pot pseudo five-component reaction of hydrazine hydrate and ethyl acetoacetate with isatin, malonitrile/ cyclic β-diketones and ammonium acetate/ primary aromatic amines in ethanol without using catalyst.
Keywords: Multicomponent domino reaction, spirooxindole, pyrazolo[3, 4-b]pyridine, pyrazolochromenopyridine, pyrazolopyranopyridine, pyrazoloquinolinopyridine.
Graphical Abstract
Current Organic Chemistry
Title:A Tandem and Domino Protocol for Synthesis of Chromeno-, Pyrano- and Quinolinofused Spiro[pyrazolo[3,4-b]pyridine-indolines]
Volume: 18 Issue: 19
Author(s): Sunil K. Gupta, Anand K. Arya, Sarita Khandelwal and Mahendra Kumar
Affiliation:
Keywords: Multicomponent domino reaction, spirooxindole, pyrazolo[3, 4-b]pyridine, pyrazolochromenopyridine, pyrazolopyranopyridine, pyrazoloquinolinopyridine.
Abstract: An efficient tandem and domino protocol for the synthesis of chromeno-, pyrano-, and quinolino- fused spiro[pyrazolo[3,4- b]pyridine-indolines] has been developed. The present method involves one-pot pseudo five-component reaction of hydrazine hydrate and ethyl acetoacetate with isatin, malonitrile/ cyclic β-diketones and ammonium acetate/ primary aromatic amines in ethanol without using catalyst.
Export Options
About this article
Cite this article as:
Gupta K. Sunil, Arya K. Anand, Khandelwal Sarita and Kumar Mahendra, A Tandem and Domino Protocol for Synthesis of Chromeno-, Pyrano- and Quinolinofused Spiro[pyrazolo[3,4-b]pyridine-indolines], Current Organic Chemistry 2014; 18 (19) . https://dx.doi.org/10.2174/138527281819141028114753
DOI https://dx.doi.org/10.2174/138527281819141028114753 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mesenchymal Stem Cells: Potential in Treatment of Neurodegenerative Diseases
Current Stem Cell Research & Therapy Transforming Growth Factor β Signaling Perturbation in the Loeys-Dietz Syndrome
Current Medicinal Chemistry Data Integration in Functional Analysis of MicroRNAs
Current Bioinformatics Biological Properties of Yeast-based Mannoprotein for Prospective Biomedical Applications
Combinatorial Chemistry & High Throughput Screening Monoamine Oxidase Inhibitors: Perspective Design for the Treatment of Depression and Neurological Disorders
Current Enzyme Inhibition Biologic Therapies in Primary Sjögren's Syndrome
Current Pharmaceutical Biotechnology Starting Point, Duration of Acquisition and Averaged of Time Series Over Subjects: Issues Related to the Reliability and Accuracy of the Constructed Group Bayesian Network for Resting-state fMRI Studies
Neuroscience and Biomedical Engineering (Discontinued) The Complex Role of Pro- and Anti-Inflammatory Cytokines in Cysticercosis:Immunological Lessons from Experimental and Natural Hosts
Current Topics in Medicinal Chemistry Antioxidant Phytochemicals in Pulses and their Relation to Human Health: A Review
Current Pharmaceutical Design Pyrimidine Derivatives as Potential Agents Acting on Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Meet the Editorial Board:
Current Genomics Erratum:
Current Neuropharmacology A Subsystem of Communication in Digital PET based on Ethernet and CAN
Neuroscience and Biomedical Engineering (Discontinued) Invokana (Canagliflozin) as a Dual Inhibitor of Acetylcholinesterase and Sodium Glucose Co-Transporter 2: Advancement in Alzheimer’s Disease- Diabetes Type 2 Linkage via an Enzoinformatics Study
CNS & Neurological Disorders - Drug Targets Understanding the Basis for the Association of apoE4 with Alzheimers Disease: Opening the Door for Therapeutic Approaches
Current Alzheimer Research Protein-Protein Interaction (PPI) Network: Recent Advances in Drug Discovery
Current Drug Metabolism The I.F.A.S.T. Model Allows the Prediction of Conversion to Alzheimer Disease in Patients with Mild Cognitive Impairment with High Degree of Accuracy
Current Alzheimer Research Formulation and Evaluation of α-Pinene Loaded Self-emulsifying Nanoformulation for <i>In-Vivo</i> Anti-Parkinson's Activity
Recent Patents on Nanotechnology Metabolomics and Its Practical Value in Pharmaceutical Industry
Current Drug Metabolism The Promise of Plant Polyphenols as the Golden Standard Skin Anti-Inflammatory Agents
Current Drug Metabolism